therapy with miRNA to improve the prognosis of patients with this pathology. © 2022 The Authors
Zhiyong, Ji,
Yeping, Ling,
Pingbo, Chen,
Meng, Yuxiao,
Xu, Shancai,
Wu, Pei,
Wang, Chunlei,
Ilyasova, Tatiana,
Sun, Bowen,
Shi, Huaizhang (2023) of recurrent
serious ischemic events despite standard medical
therapy, has been clinically
challenging. A
Beilerli, A.,
Kudriashov, V.,
Sufianov, A.,
Kostin, A.,
Begliarzade, S.,
Ilyasova, T.,
Liang, Ya.,
Mukhamedzyanov, A.,
Beylerli, O. (2023) resistance and promising directions for targeted
therapy. This review presents the results of scientific
in the expression of miRNAs)
and designing their targeted
therapy using specific miRNAs as targets. This article
Valeeva, E.T.,
Galimova, R.R.,
Distanova, A.A.,
Suleymanova, I.F.,
Suleymanova, I.F.,
Boyarinova, N.B.,
Salavatova, L.Kh.,
Isaeva, S.M. (2023) non-communicable diseases such as diseases of the circulatory
system (CSDs), occupational